Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance
Aurélie Guigon, Emmanuel Faure, C. Lemaire, Marie‐Charlotte Chopin, Claire Tinez, Ady Assaf, Mouna Lazrek, Didier Hober, Laurence Bocket, Ilka Engelmann, Enagnon Kazali Alidjinou
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Spike ProteinMonoclonal antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyClinical trialVirologyDiseaseInternal medicineImmunologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations